Please Wait...

  • +91 22 2783 1455

  • Product background
    CIPROFLOXACIN OPHTHALMIC

WARNING: CAUTION : PLEASE NOTE :
The content or product detailing is not intended to replace advice from your prescribing doctor or healthcare professional. Lavina Pharma is not responsible for such actions by consumers. For any further information about the product please contact +91 22 2783 1455 and we can provide you the details.

CIPROFLOXACIN OINTMENT USP 0.3 % W/W
CIPROFLOXACIN EYE / EAR DROP

Ciprofloxacin ophthalmic ointment is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the microorganisms listed below:
Gram-Positive: Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus Viridans Group
Gram-Negative: Haemophilus influenzae

COMPOSITION (OINTMENT)

Ciprofloxacin Hydrochloride USP
Equivalent to Ciprofloxacin USP… 0.3% w/w
Benzalkonium Chloride NF… 0.01 % w/w
Sterile Ointment base… Q.s

COMPOSITION (DROPS)

Ciprofloxacin Hydrochloride USP
Equivalent to Ciprofloxacin USP… 0.3% w/v
Benzalkonium Chloride NF… 0.02 % v/v (as preservative)
Sterile aqueous buffered vehicle… Q.s

DOSAGE

For bacterial conjunctivitis –

Apply a 1/2 inch ribbon into the conjunctival sac three times a day on the first two days, then apply a 1/2inch ribbon two times a day for the next five days.

Ophthalmic Drops: For bacterial conjunctivitis

Adults & Children –

Put 1 or 2 drops in the affected eye every 2 hours, while awake, for 2 days. Then put 1 or 2 drops in the affected eye every 4 hours, while awake, for the next 5 days.

SIDE EFFECT
Ciprofloxacin Ophthalmic Ointment may cause temporarily sting or burn in eyes for a minute or two when applied. Blurred vision, eye discomfort, itching, and redness, tearing & dry eyes, feeling as if something is in eye, a bad taste in mouth, or sensitivity to light may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

PRECAUTION
Ciprofloxacin may result in overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated. Ciprofloxacin should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity reaction.



PRESENTATION
5-gram sterile ointment supplied in aluminium tube with white polyethylene tip & white polyethylene cap. Drops: 5 ml of Eto sterile white bottle.